Author

B. Ziman

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 3 Approach:statistical model· 3 Research Focus:chromatin & epigenetic regulation· 2 Assay:DNA methylation· 2 Organism:human· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1

Frequent Co-Authors

Y. Zheng· 3 shared D.-C. Lin· 2 shared H. Zhao· 2 shared A. E. Lyashkov· 1 shared A. Gupta· 1 shared A. J. Silvester· 1 shared A. Kalra· 1 shared A. S. Ho· 1 shared

Activity by Year

2022-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Y. Zheng

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Epigenomic Analyses Identify FOXM1 As a Key Regulator of Anti-Tumor Immune Response in Esophageal Adenocarcinoma

B. Ziman, Q. Yang, Y. Zheng, M. Sheth, C. Nam, H. Zhao, U. Sinha, D. Lin

This study identifies FOXM1 as an epigenetic regulator in EAC that suppresses anti-tumor immune responses by inhibiting CD8+ T cell infiltration and function.

bioRxiv · Jul 28, 2023Cancer Biology

Comprehensive analyses of partially methylated domains and differentially methylated regions in esophageal cancer reveal both cell-type- and cancer-specific epigenetic regulation

Y. Zheng, B. Ziman, A. S. Ho, U. K. Sinha, L.-Y. Xu, E.-M. Li, B. P. Berman, D.-C. Lin

This study identifies cell-type- and cancer-specific epigenetic features in esophageal cancer using whole-genome bisulfite sequencing, revealing novel insights into DNA methylation dynamics.

bioRxiv · Aug 18, 2022Cancer Biology

A Remarkable Adaptive Paradigm Of Heart Performance And Protection Emerges In Response To The Constitutive Challenge Of Marked Cardiac-Specific Overexpression Of Adenylyl Cyclase Type 8

K. V. Tarasov, K. Chakir, D. R. Riordon, A. E. Lyashkov, I. Ahmet, M. G. Perino, A. J. Silvester, J. Zhang, M. Wang, Y. O. Lukyanenko, J.-H. Qu, M. C.-R. Barrera, M. Juhaszova, Y. S. Tarasova, B. Ziman, , E. G. Lakatta

This study shows that cardiac-specific overexpression of AC8 in mice leads to adaptive cardiac changes resembling cancer-like survival mechanisms without heart failure.

bioRxiv · May 20, 2022Physiology

Novel tumorigenic FOXM1-PTAFR-PTAF axis revealed by multi-omic profiling in TP53/CDKN2A-double knockout human gastroesophageal junction organoid model

H. Zhao, Y. Cheng, A. Kalra, K. Ma, Y. Zheng, B. Ziman, C. Tressler, K. Glunde, E. J. Shin, S. Ngamruengphong, M. Khashab, V. Singh, R. A. Anders, S. Jit, N. Wyhs, , S. J. Meltzer

bioRxiv · May 10, 2022 · PreprintCancer Biology